IL-22 protects mice from IBD by promoting epithelial cell proliferation, restoring goblet cells, and restoring the expression of tight junction proteins, such as Claudin-1, Zo-1, and E-cadherin (He et al. 2022; Sugimoto et al. 2008). This evidence concerns the gene IL22 and inflammatory bowel disease.